This inventor holds 2 USPTO granted patents. Top assignee: Glaxo Group Limited. Active years: 1994-1995.
Company Filing History:
Years Active: 1994-1995
Title: Michael V Hayes - Innovator in Biochemical Research
Introduction
Michael V Hayes is a notable inventor based in Greenford, GB. He has made significant contributions to the field of biochemical research, particularly in the development of compounds that have potential therapeutic applications. With a total of 2 patents to his name, Hayes continues to push the boundaries of innovation in his field.
Latest Patents
One of his latest patents involves cyclic ketal derivatives, which are described by a specific formula. These compounds are designed to inhibit the enzyme squalene synthase and serve as intermediates for the preparation of other compounds that also inhibit this enzyme. The invention highlights the potential for these compounds to be formulated for various conditions, including lowering blood plasma cholesterol levels and combating fungal infections in animals. Another patent focuses on a biologically pure culture of the microorganism Phoma sp. IMI 332962 or a mutant thereof, showcasing his diverse research interests.
Career Highlights
Michael V Hayes is associated with Glaxo Group Limited, a company known for its commitment to pharmaceutical innovation. His work at Glaxo has allowed him to explore various avenues in biochemical research, contributing to advancements in health and medicine.
Collaborations
Throughout his career, Hayes has collaborated with notable colleagues, including Allan Baxter and Nigel Stephen Watson. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Michael V Hayes exemplifies the spirit of innovation in the field of biochemical research. His contributions through patents and collaborations continue to impact the industry positively.